Ligand validation:6H0F

Y70: S-Pomalidomide

Y70 is a Ligand Of Interest in 6H0F designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6H0F_Y70_H_502	47%	73%	0.235	0.975	0.27	0.75	-	2	0	0	100%	1
6H0F_Y70_B_502	43%	73%	0.238	0.962	0.29	0.74	-	2	0	0	100%	1
6H0F_Y70_K_502	36%	72%	0.272	0.966	0.29	0.75	-	2	0	0	100%	1
6H0F_Y70_E_502	27%	74%	0.327	0.979	0.26	0.73	-	2	0	0	100%	1
8OIZ_Y70_B_502	65%	73%	0.143	0.947	0.4	0.62	-	2	0	0	100%	0.92
8U16_Y70_D_502	48%	40%	0.212	0.958	0.98	1.4	1	5	2	0	100%	1
8U17_Y70_D_502	25%	69%	0.191	0.827	0.25	0.91	-	1	0	0	100%	1
4V2Z_Y70_B_151	90%	2%	0.08	0.962	2.96	4.06	7	15	0	0	100%	1
4TZU_Y70_A_504	69%	16%	0.122	0.938	2.13	1.76	4	9	0	0	100%	1
4CI3_Y70_B_1429	42%	29%	0.239	0.961	0.89	2.05	1	9	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.